Browse by Author

Browse by Year

Browsing publications by Dr Charles Kelly

Newcastle AuthorsTitleYearFull text
Dr Charles Kelly
Chemotherapy: United Kingdom National Multidisciplinary Guidelines2016
Professor Vinidh Paleri
Dr Charles Kelly
Recurrent and second primary squamous cell carcinoma of the head and neck: When and how to reirradiate2015
Professor Vinidh Paleri
Dr Charles Kelly
Small cell neuroendocrine carcinoma of larynx: Case series and literature review2015
Professor Vinidh Paleri
Dr Alastair Greystoke
Dr Charles Kelly
Spindle cell carcinoma of the head and neck region: Treatment and outcomes of 15 patients2015
Dr Charles Kelly
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study2014
Dr Joanne Patterson
Professor Elaine McColl
Professor Paul Carding
Anthony Hildreth
Dr Charles Kelly
et al.
Swallowing in the first year after chemoradiotherapy for head and neck cancer: Clinician- and patient-reported outcomes2014
Dr Ross Maxwell
Dr John Wilsdon
Dr Charles Kelly
Variation in Radiotherapy Target Volume Definition, Dose to Organs at Risk and Clinical Target Volumes using Anatomic (Computed Tomography) versus Combined Anatomic and Molecular Imaging (Positron Emission Tomography/Computed Tomography): Intensity-modulated Radiotherapy Delivered using a Tomotherapy Hi Art Machine: Final Results of the VortigERN Study2012
Professor Vinidh Paleri
Professor Paul Carding
Dr Sanjoy Chatterjee
Dr Charles Kelly
Professor Janet Wilson
et al.
Voice outcomes after concurrent chemoradiotherapy for advanced nonlaryngeal head and neck cancer: A prospective study2012
Dr Sanjoy Chatterjee
Dr John Wilsdon
Dr Judith Mott
Paddy Stevenson
Dr Ross Maxwell
et al.
Final Results of Vortigern Study: CT Versus Pet-CT Based Tomotherapy Voluming and Dose Escalation in Oropharyngeal Squamous Cell Carcinoma (ISRCTN 33175361, UKCRN ID: 08/h0907/127) [meeting abstract]2011
Dr Charles Kelly
Professor Vinidh Paleri
Quality-of-life considerations in treatment of unresectable, recurrent head and neck cancer2010
1234